跳至主要内容
临床试验/NL-OMON43056
NL-OMON43056已完成2 期

Preoperative staging by combidex MRI in patients with resectable esophageal carcinoma - PRECIES study

Radboud Universitair Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Patients with histologically proven primary esophageal adenocarcinoma or squamous cell carcinoma, who are planned to undergo a esophagectomy after nCRT
  • * Patients with suspected lymph nodes metastases on EUS or CT before nCRT
  • * Age > 18 years
  • * Providing informed consent

排除标准

  • * Unable to provide informed consent
  • * Known pregnancy or breastfeeding
  • * Contra-indications for MRI
  • - Epilepsy
  • - Metal implants that are not compatible with MRI
  • * Contra-indications for USPIO based contrast agents
  • - Prior allergic reaction to ferumoxtran-10 or any other iron preparation
  • - Prior allergic reaction contributed to dextran or other polysaccharide, in any preparation
  • - Prior allergic reaction to contrast media of any type
  • - Hereditary hemochromatosis, thalassemia, sickle cell anemia
  • - Inflammatory diseases of the abdomen

研究者

相似试验